1. Single-dose extended-release oral azithromycin vs
Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A β-haemolytic streptococcal pharyngitis/tonsillitis in adults and adolescents: a double-blind, double-dummy study 
D.M. Jorgensen 
Clinical Microbiology and Infection 
Volume 15, Issue 12, Pages (December 2009)
DOI: /j x
Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

2. FIG. 1
CONSORT flow diagram for the double-blind, double-dummy study evaluating the azithromycin extended-release formulation (AZ-ER) vs. the immediate-release formulation (AZ-IR). TOC, test-of-cure; BPP, bacteriological per-protocol population; LTFU, long-term follow-up; GABHS, group A β-haemolytic streptococcus.
Clinical Microbiology and Infection  , DOI: ( /j x)
Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

3. FIG. 2
Rates of (a) bacteriological eradication and (b) clinical cure at test-of-cure (TOC) and continued at long-term follow-up (LTFU) in those subjects with eradication at the TOC visit and cured at the TOC visit, respectively (bacteriological per-protocol population). AZ-ER, azithromycin extended-release formulation; AZ-IR, azithromycin immediate-release formulation. [For the LTFU analyses, evaluable subjects in the bacteriologic per-protocol population also had to be classified as having bacteriological eradication at the TOC visit. Similarly, in Figure 2b, the LTFU evaluable subjects in the bacteriological per-protocol population also had to be classified as having a clinical cure at the TOC visit.]
Clinical Microbiology and Infection  , DOI: ( /j x)
Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions